NASDAQ
Kuros Biosciences AG (CSBTF) has a free cash flow growth of 124.43% as of Friday, May 29, 2026. This represents a 54.80% increase compared to its 12-month average of 80.38%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.